Description
Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH). It was developed as a neuroactive research peptide and has mainly been studied for its effects on cognition, brain function and protection of nerve cells.
Research has explored Semax in relation to memory, attention, learning, cerebral blood flow and neuroprotection. Laboratory work has also looked at its effects on signalling systems involved in neuronal survival and brain-derived neurotrophic factor (BDNF), a protein involved in the growth, maintenance and adaptability of nerve cells.
In plain English: researchers are interested in Semax because it may influence how well the brain handles stress, learning, memory and recovery from certain types of neurological damage. It is often discussed as a nootropic research peptide because studies have looked at whether it may support focus, memory and cognitive performance while also helping protect nerve cells under stressful conditions.
Semax has been studied in both laboratory research and human clinical studies, particularly in neurological settings such as ischaemic stroke and rehabilitation. Some studies have reported improvements in neurological recovery, motor function and markers such as BDNF, although much of the published clinical research comes from a relatively small number of research groups and further large, independent studies are still needed.
Supplied by Black Knight Peptides for laboratory and research purposes only.
Not for human consumption.
